Transfusion avoidance in orthopedic surgery

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 18, Issue 4 SUPPL., 2004, Pages S29-S30

  Cushner, Fred D ^a  

^a BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APROTININ; ERYTHROPOIETIN; HEMOGLOBIN;

ARTHROPLASTY; BLOOD TRANSFUSION; HEMATOCRIT; HEMOGLOBIN DETERMINATION; HUMAN; KNEE ARTHROPLASTY; ORTHOPEDIC SURGERY; PRIORITY JOURNAL; SHORT SURVEY; THROMBOSIS;

EID: 4444377605     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jvca.2004.05.003     Document Type: Article

References (19)

1. Patterson F.P., Brown C.S. Complications of total hip replacement arthroplasty. Orthop Clin North Am. 4:1973;503-512
2. Berman A.T., Geissele A.E., Bosacco S.J. Blood loss with total knee arthroplasty. Clin Orthop. 234:1988;137-138
3. Cushner F.D., Friedman R.J. Blood loss in total knee arthroplasty. Clin Orthop. 269:1991;98-101
4. Cushner F.D., Scott W.N. Evolution of blood transfusion management for a busy knee practice. Orthopedics. 22:1999;S145-147
5. Cushner F., Scuderi G. The fallacy of autologous blood donations. 2002;Closed Knee Society Meeting, Philadelphia, PA
6. Pagnano M., Cushner F.D., Hansen A., et al. Blood management in two-stage revision knee arthroplasty for deep prosthetic infection. Clin Orthop. 367:1999;238-242
7. Cushner F.D., Locker J.R., Hanssen A.D., et al. Use of recombinant human erythropoietin in two-stage total knee arthroplasty for infection. Clin Orthop. 392:2001;116-123
8. Kasper S.M., Elsner F., Hilgers D., et al. A retrospective study of the effects of small-dose aprotinin on blood loss and transfusion needs during total hip arthroplasty. Eur J Anaesthesiol. 15:1998;669-675
9. Janssens M., Joris J., David J.L., et al. High-dose aprotinin reduces blood loss in patients undergoing total hip replacement surgery. Anesthesiology. 80:1994;23-29
10. Langdown A.J., Field J., Grote J., et al. Aprotinin (Trasylol) does not reduce bleeding in primary total hip arthroplasty. J Arthroplasty. 15:2000;1009-1012
11. Murkin J.M., Shannon N.A., Bourne R.B., et al. Aprotinin decreases blood loss in patients undergoing revision or bilateral total hip arthroplasty. Anesth Analg. 80:1995;343-348
12. Haas S., Mueller E., Fritsche H. Effect of aprotinin on the incidence of thrombosis and postoperative bleeding. Thromb Haem. 54:1985;99-103
13. Hayes A., Murphy D.B., McCarroll M. The efficacy of single-dose aprotinin 2 million KIU in reducing blood loss and its impact on the incidence of deep venous thrombosis in patients undergoing total hip replacement surgery. J Clin Anesth. 8:1996;357-360
14. Singbartl G., Kantak S., Munkel H. Transfusion-related cost of adjunct aprotinin application in one-step infected hip revision arthroplasty - Cost minimizing analysis. Infus Ther Transfus Med. 28:2001;74-79
15. Thorpe C.M., Murphy W.G., Logan M. Use of aprotinin in knee replacement surgery. Br J Anaesth. 73:1994;408-410. [see comments]
16. Singbartl G., Kantak S., Munkel H. Adjunct aprotinin administration is at least a cost-neutral blood saving measure in infective knee revision surgery. Curr Opin Clin Exp Res. 3:2001;146-154
17. Rochette A., Canaud N., Gariglio A., et al. Aprotinin decreases transfusion requirements by 50 percent in posterior spinal fusion. Anesthesiology. 87:1997;1068-1071
18. Urban M.K., Beckman J., Gordon M., et al. The efficacy of antifibrinolytics in the reduction of blood loss during complex adult reconstructive spine surgery. Spine. 26:2001;1152-1156
19. Lentschener C., Cottin P., Bouaziz H., et al. Reduction of blood loss and transfusion requirement by aprotinin in posterior lumbar spine fusion. Anesth Analg. 89:1999;590-597